92 related articles for article (PubMed ID: 9439908)
1. Thyroid function in preterm newborns; is T4 treatment required in infants < 27 weeks' gestational age?
Van Wassenaer AG; Kok JH; Briët JM; van Baar AL; de Vijlder JJ
Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():12-8. PubMed ID: 9439908
[TBL] [Abstract][Full Text] [Related]
2. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
van Wassenaer AG; Westera J; Houtzager BA; Kok JH
Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
[TBL] [Abstract][Full Text] [Related]
3. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
4. Thyroid function in very preterm newborns: possible implications.
Van Wassenaer AG; Kok JH; Briët JM; Pijning AM; de Vijlder JJ
Thyroid; 1999 Jan; 9(1):85-91. PubMed ID: 10037082
[TBL] [Abstract][Full Text] [Related]
5. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia.
Chowdhry P; Scanlon JW; Auerbach R; Abbassi V
Pediatrics; 1984 Mar; 73(3):301-5. PubMed ID: 6366725
[TBL] [Abstract][Full Text] [Related]
6. Thyroid function in very preterm infants: influences of gestational age and disease.
van Wassenaer AG; Kok JH; Dekker FW; de Vijlder JJ
Pediatr Res; 1997 Nov; 42(5):604-9. PubMed ID: 9357931
[TBL] [Abstract][Full Text] [Related]
7. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants.
van Wassenaer AG; Briët JM; van Baar A; Smit BJ; Tamminga P; de Vijlder JJ; Kok JH
Pediatrics; 2002 Sep; 110(3):534-9. PubMed ID: 12205256
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants.
Bierer R; Peceny MC; Hartenberger CH; Ohls RK
Pediatrics; 2006 Sep; 118(3):e635-40. PubMed ID: 16908620
[TBL] [Abstract][Full Text] [Related]
9. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
[TBL] [Abstract][Full Text] [Related]
10. The thyroid-system function in preterm infants of postmenstrual ages of 31 weeks or less: evidence for a "transient lazy thyroid system".
Eggermont E; Vanderschueren-Lodeweyckx M; De Nayer P; Smeets E; Vanacker G; Cornette C; Jaeken J; Devlieger H; Eeckels R; Beckers C
Helv Paediatr Acta; 1984 Aug; 39(3):209-22. PubMed ID: 6544306
[TBL] [Abstract][Full Text] [Related]
11. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants.
Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU
Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556
[TBL] [Abstract][Full Text] [Related]
12. Improving head growth in preterm infants--a randomised controlled trial II: MRI and developmental outcomes in the first year.
Tan M; Abernethy L; Cooke R
Arch Dis Child Fetal Neonatal Ed; 2008 Sep; 93(5):F342-6. PubMed ID: 18285378
[TBL] [Abstract][Full Text] [Related]
13. Trials with thyroid hormone in preterm infants: clinical and neurodevelopmental effects.
van Wassenaer AG; Kok JH
Semin Perinatol; 2008 Dec; 32(6):423-30. PubMed ID: 19007681
[TBL] [Abstract][Full Text] [Related]
14. No change in developmental outcome with incubator covers and nesting for very preterm infants in a randomised controlled trial.
Maguire CM; Walther FJ; van Zwieten PH; Le Cessie S; Wit JM; Veen S;
Arch Dis Child Fetal Neonatal Ed; 2009 Mar; 94(2):F92-7. PubMed ID: 18703571
[TBL] [Abstract][Full Text] [Related]
15. Thyroid function in the preterm infant.
LaFranchi S
Thyroid; 1999 Jan; 9(1):71-8. PubMed ID: 10037080
[TBL] [Abstract][Full Text] [Related]
16. Very preterm birth is associated with disabilities in multiple developmental domains.
van Baar AL; van Wassenaer AG; Briët JM; Dekker FW; Kok JH
J Pediatr Psychol; 2005; 30(3):247-55. PubMed ID: 15784921
[TBL] [Abstract][Full Text] [Related]
17. Increasing supplemental thyroid hormone use among premature infants born at 23 to 32 weeks' gestation.
Linn M; Yoder BA; Clark RH
Am J Perinatol; 2010 Oct; 27(9):731-5. PubMed ID: 20408110
[TBL] [Abstract][Full Text] [Related]
18. Adverse neurodevelopmental outcome in preterm infants: risk factor profiles for different gestational ages.
Kiechl-Kohlendorfer U; Ralser E; Pupp Peglow U; Reiter G; Trawöger R
Acta Paediatr; 2009 May; 98(5):792-6. PubMed ID: 19191762
[TBL] [Abstract][Full Text] [Related]
19. Outcome at 2 years of children 23-27 weeks' gestation born in Victoria in 1991-92. The Victorian Infant Collaborative Study Group.
J Paediatr Child Health; 1997 Apr; 33(2):161-5. PubMed ID: 9145362
[TBL] [Abstract][Full Text] [Related]
20. Outcome of infants born at 24-26 weeks' gestation: II. Neurodevelopmental outcome.
Piecuch RE; Leonard CH; Cooper BA; Kilpatrick SJ; Schlueter MA; Sola A
Obstet Gynecol; 1997 Nov; 90(5):809-14. PubMed ID: 9351769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
